Alimera Sciences, Inc. (ALIM) Social Stream
Alimera Sciences Inc (ALIM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALIM.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 1 | $12 | $12 | $12 | $5.65 | 112.39% |
| 2022-02-25 | 1 | $10 | $10 | $10 | $5.65 | 76.99% |
Price Target Last Issued February 25, 2022
The Trend in the Analyst Price Target
ALIM's average price target has moved down $3.5 over the prior 14 months.
Over the past 46 weeks, ALIM's average upside potential has been 109.28%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-10 | 0 | 18 | 10 | 14.25 | 9.56 | 49.06% |
| 2021-07-24 | 0 | 18 | 15 | 16.38 | 8.91 | 83.84% |
| 2021-08-01 | 0 | 18 | 15 | 16.38 | 8.83 | 85.5% |
| 2021-08-14 | 0 | 18 | 15 | 16.38 | 7.31 | 124.08% |
| 2021-09-04 | 0 | 18 | 12 | 14.88 | 6.02 | 147.18% |
ALIM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
ALIM's average broker recommendation rating improved by 1 over the prior 123 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Alimera Sciences Inc's number of analysts covering the stock is greater than just about none of of them.
- ALIM has a lower variance in analysts' estimates than just about 100% of all US stocks.
- Alimera Sciences Inc's average analyst price target is greater than 35.18% of Healthcare stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Alimera Sciences Inc's upside potential (average analyst target price relative to current price) is greater than 70.22% of them.
In the Pharmaceutical Products industry, ALDX, ALBO, and AKUS are the three stocks most similar to Alimera Sciences Inc regarding the price target and analyst recommendation information presented here.
Is ALIM a Buy, Hold or Sell? See the POWR Ratings now!